Intracameral phenylephrine/ketorolac superior to intracamera
Efforts to improve the performance and outcomes of cataract surgery continue, and surgeons have taken another step forward in that regard.The addition of intracameral phenylephrine/ketorolac to the surgical regimen is known to maintain pupillary dilation.

In addition, investigators also found the drug combination of phenylephrine 1.0% and ketorolac 0.3% (Omidria, Omeros Corp.) was superior to intracameral epinephrine by decreasing the rates of intraocular complications, the necessity for using pupillary dilation devices during cataract surgery, the length of the surgery, and best-corrected visual acuity (BCVA) outcomes.

http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/intracameral-phenylephrineketorolac-superior-intracameral-epinephrine
Like
Comment
Share